Microsoft has ended support for its pre-IE11 browsers as of January 2016 and will be discontinuing IE11 support in August 2021.

If you are seeing this message, you are viewing the site on one of these unsupported browsers. We only support the recent versions of major browsers such as Chrome, Firefox, Safari, and Edge.

Thank you.

(click to close and continue using this browser)

Home Research The SUFU Research Network (SURN)

The SUFU Research Network (SURN)

SURN is a collaborative entity of SUFU members to promote and conduct multicenter, clinical research. The mission of SURN is to conduct high quality multicenter clinical studies related to SUFU areas of interest that have greater impact than single center studies, to provide access to high quality research opportunities and mentorship for interested SUFU members and to successfully collaborate and build toward future clinical trial/research development.

Since its inception in 2016, SURN has conducted two multicenter studies. The first study evaluated use of onabotulinum toxin for idiopathic overactive bladder and the second described outcomes of surgical management of female urethral stricture disease. The network has published three manuscripts based on these two studies. SURN’s organizational structure consists of an advisory board and steering committee.

How to Get Involved

The SURN is comprised of individual SUFU members with interest in participating in multi-center clinical research.

  1. Active SUFU Membership (Affiliate or Active Member) in good standing
  2. SURN Membership is attained through application to and approval by the Steering Committee. Qualifications include interest and motivation to perform the research activities.
  3. Non-SUFU members can also apply to be a member of the SURN and may be approved by the steering committee. Non-SUFU members may serve as collaborators in research studies and their research activities will be coordinated by the PI of the research study.

Apply for SURN Membership

  • ()-
  • Address
  • State

SURN Bibliography

Reynolds WS, Suskind AM, Anger JT, Brucker BM, Cameron AP, Chung DE, Daignault-Newton S, Lane GI, Lucioni A, Mourtzinos AP, Padmanabhan P, Reyblat PX, Smith AL, Tenggardjaja CF, Lee UJ; SUFU Research Network. Incomplete bladder emptying and urinary tract infections after botulinum toxin injection for overactive bladder: Multi-institutional collaboration from the SUFU research network. Neurourol Urodyn. 2022 Feb;41(2):662-671. doi: 10.1002/nau.24871. Epub 2022 Jan 12. PMID: 35019167; PMCID: PMC8891079.

Lane GI, Gracely A, Uberoi P, Lee U, Smith AL, Anger JT, Theva D, DeLong J, Kowalik C, Padmanabhan P, Powell CR, Carmel ME, Clemens JQ, Cameron AP, Gupta P; SUFU Research Network. Changes in patient reported outcome measures after treatment for female urethral stricture. Neurourol Urodyn. 2021 Apr;40(4):986-993. doi: 10.1002/nau.24653. Epub 2021 Mar 14. PMID: 33719145.

Lane GI, Smith AL, Stambakio H, Lin G, Al Hussein Alawamlh O, Anger JT, Brandes ER, Carmel ME, Chung DE, Cox L, DeLong J, Elliott CS, Eltahawy E, Aparecido França W, Gousse A, Gupta P, Hagedorn JC, High RA, Khan A, Kowalik C, Lee RK, Lee UJ, Lucioni A, MacDonald S, Malaeb B, McKay S, Padmanabhan P, Powell CR, Sajadi KP, Sutherland SE, Theva D, Vollstedt A, Welk B, Zheng Y, Cameron AP; Society of Urodynamics, Female Pelvic Medicine and Urogenital Reconstruction Research Network (SURN). Treatment of urethral stricture disease in women: A multi-institutional collaborative project from the SUFU research network. Neurourol Urodyn. 2020 Nov;39(8):2433-2441. doi: 10.1002/nau.24507. Epub 2020 Sep 14. PMID: 32926460.